RMD ResMed Inc.
Platform & Compounding FCF
A- 85.6 / 100 composite

AlphaQuality composite grade, weighted for platform & compounding fcf businesses.

Profitability

Weight: 25%
A- 80
  • 5yr Avg ROIC 14.8%
  • Operating Margin Trend +0.92 pp/yr

Capital Efficiency

Weight: 15%
B 74
  • 5yr Avg ROE 15.3%
  • 5yr Share-Count CAGR 0.2%

Growth Quality

Weight: 25%
A+ 94
  • 5yr Revenue CAGR 12.6%
  • 5yr EPS CAGR 30.9%
  • Revenue-Growth Years (5) 5/5

Cash Generation

Weight: 20%
A 91
  • 5yr FCF Margin 19.6%
  • 5yr FCF/NI Conversion 0.93x

Balance Sheet

Weight: 10%
A+ 98
  • Net Debt / EBITDA -0.19x
  • Interest Coverage (EBIT/Int) 133.05x
  • Altman Z-Score 10.76

Stability

Weight: 5%
C+ 60
  • EPS Volatility (σ/μ) 0.55
  • Piotroski F-Score 7
  • Negative-Revenue Years (5) 0/5

Guru Flow

Curated superinvestor sentiment — not part of the AlphaQuality grade.
Holding

4 of 4 gurus held; 2 added; 1 trimmed.

Holders
4
Avg Δ position
-4.9%
New buys
0
Full exits
0
As of Q1 2026